Guizhou Xinbang Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 2,702.504 million compared to CNY 3,277.630 million a year ago. Operating income was CNY 48.234 million compared to CNY 154.837 million a year ago. Net income was CNY 35.748 million compared to CNY 121.320 million a year ago. Basic earnings per share from continuing operations was CNY 0.02 compared to CNY 0.07 a year ago.